Abstract
Compared to cancer in adults, childhood cancer is rare, accounting for significantly less than 1% of all cancer diagnoses. Since increasing age constitutes a significant risk factor for the development of cancer, it is supposed that the overall prevalence of cancer will continuously increase while the average life expectancy rises. In contrast, birthrates are declining in most western countries, thus leading to a further decline of the overall incidence rate of childhood cancer. Thus, the question arises, what will define a rare tumor in childhood and adolescence, if the overall numbers are generally low. Is a rare cancer defined only by incidence numbers, or do specific clinical, pathological, or biological characteristics define a tumor to be rare?
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Baranzelli MC, Flamant F et al (1993) Treatment of non-metastatic, non-seminomatous malignant germ-cell tumours in childhood: experience of the “Societe Francaise d’Oncologie Pediatrique” MGCT 1985–1989 study. Med Pediatr Oncol 21(6):395–401
Brecht IB, Graf N et al (2009) Networking for children and adolescents with very rare tumors: foundation of the GPOH Pediatric Rare Tumor Group. Klin Pädiatr 221(3):181–185
Cerroni L, Barnhill R et al (2010) Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008. Am J Surg Pathol 34(3):314–326
Cushing B, Giller R et al (2004) Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a Pediatric Intergroup Study – Pediatric Oncology Group 9049 and Children’s Cancer Group 8882. J Clin Oncol 22(13):2691–2700
Demetri GD, van Oosterom AT et al (2006) Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet 368(9544):1329–1338
Ducharme EE, Silverberg NB (2009) Pediatric malignant melanoma: an update on epidemiology, detection, and prevention. Cutis 84(4):192–198
Durno C, Aronson M et al (2005) Family history and molecular features of children, adolescents, and young adults with colorectal carcinoma. Gut 54(8):1146–1150
Erdman SH (2007) Pediatric adenomatous polyposis syndromes: an update. Curr Gastroenterol Rep 9(3):237–244
Ferrari A, Sultan I (2010) When adult cancers occur in children. Expert Rev Anticancer Ther 10(11):1683–1685
Ferrari A, Bono A et al (2005) Does melanoma behave differently in younger children than in adults? A retrospective study of 33 cases of childhood melanoma from a single institution. Pediatrics 115(3):649–654
Ferrari A, Bisogno G et al (2007) The challenge of very rare tumours in childhood: the Italian TREP project. Eur J Cancer 43(4):654–659
Ferrari A, Rognone A et al (2008) Colorectal carcinoma in children and adolescents: the experience of the Istituto Nazionale Tumori of Milan, Italy. Pediatr Blood Cancer 50(3):588–593
Ferrari A, Casanova M et al (2010) Peculiar features and tailored management of adult cancers occurring in pediatric age. Expert Rev Anticancer Ther 10(11):1837–1851
Göbel U, Calaminus G et al (2002) Management of germ cell tumors in children: approaches to cure. Onkologie 25(1):14–22
Half EE, Bresalier RS (2004) Clinical management of hereditary colorectal cancer syndromes. Curr Opin Gastroenterol 20(1):32–42
Hill DA, Furman WL et al (2007) Colorectal carcinoma in childhood and adolescence: a clinicopathologic review. J Clin Oncol 25(36):5808–5814
Hill DA, Ivanovich J et al (2009) DICER1 mutations in familial pleuropulmonary blastoma. Science 325(5943):965
Janeway KA, Albritton KH et al (2009) Sunitinib treatment in pediatric patients with advanced GIST following failure of imatinib. Pediatr Blood Cancer 52(7):767–771
Lo Curto M, Lumia F et al (2003) Malignant germ cell tumors in childhood: results of the first Italian cooperative study “TCG 91”. Med Pediatr Oncol 41(5):417–425
Lopes LF, Macedo CR et al (2009) Cisplatin and etoposide in childhood germ cell tumor: brazilian pediatric oncology society protocol GCT-91. J Clin Oncol 27(8):1297–1303
Mann JR, Raafat F et al (2000) The United Kingdom Children’s Cancer Study Group’s second germ cell tumor study: carboplatin, etoposide, and bleomycin are effective treatment for children with malignant extracranial germ cell tumors, with acceptable toxicity. J Clin Oncol 18(22):3809–3818
Ortega JA, Douglass EC et al (2000) Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children’s Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18(14):2665–2675
Pappo AS (2003) Melanoma in children and adolescents. Eur J Cancer 39(18):2651–2661
Pastore G, De Salvo GL et al (2009) Evaluating access to pediatric cancer care centers of children and adolescents with rare tumors in Italy: the TREP project. Pediatr Blood Cancer 53(2):152–155
Perilongo G, Shafford E et al (2004) Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology–SIOPEL 2. Eur J Cancer 40(3):411–421
Perilongo G, Maibach R et al (2009) Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma. N Engl J Med 361(17):1662–1670
Ries LA, Smith MAS, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds) (1999) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975–1995, National Cancer Institute, SEER Program, NIH Publication No. 99–4649. National Cancer Institute, Bethesda
Saab R, Furman WL (2008) Epidemiology and management options for colorectal cancer in children. Paediatr Drugs 10(3):177–192
Schneider DT, Calaminus G et al (2004) Epidemiologic analysis of 1,442 children and adolescents registered in the German germ cell tumor protocols. Pediatr Blood Cancer 42(2):169–175
Smith MA, Seibel NL et al (2010) Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28(15):2625–2634
Strouse JJ, Fears TR et al (2005) Pediatric melanoma: risk factor and survival analysis of the surveillance, epidemiology and end results database. J Clin Oncol 23(21):4735–4741
Sultan I, Rodriguez-Galindo C et al (2010) Distinct features of colorectal cancer in children and adolescents: a population-based study of 159 cases. Cancer 116(3):758–765
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Olson, T.A., Schneider, D.T., Brecht, I.B., Ferrari, A. (2012). Rare Tumors: A Different Perspective on Oncology. In: Schneider, D., Brecht, I., Olson, T., Ferrari, A. (eds) Rare Tumors In Children and Adolescents. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04197-6_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-04197-6_1
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-04196-9
Online ISBN: 978-3-642-04197-6
eBook Packages: MedicineMedicine (R0)